GUARDANT HEALTH INC / SOFTBANK GROUP CORP / Acquisition / Private / £247m

Synopsis

Sale of a 35% stake in Guardant Health, a provider of sequencing and rare-cell diagnostics services focusing on cancer, to Softbank Group Capital.

Principals

Guardant Health

Softbank Group Corp

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

latham & watkins

HQ - New York, United States

legal advisors

target

5557

Deals

£ 3,639.15 B

Total Value